Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-021570
Filing Date
2024-08-19
Accepted
2024-08-19 16:15:08
Documents
1
Period of Report
2024-08-15

Document Format Files

Seq Description Document Type Size
1 form4-08192024_040801.html 4  
1 form4-08192024_040801.xml 4 7280
  Complete submission text file 0001415889-24-021570.txt   8857
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Issuer) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ELEVATION ONCOLOGY, INC. 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106
Business Address
Furlong Tammy (Reporting) CIK: 0001984204 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40523 | Film No.: 241220719